376 AZD3355, a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxations in the Dog
Anders Lehmann(AstraZeneca (United Kingdom)), Sverker von Unge, Lena Brändén, Anita Carlsson(AstraZeneca (Sweden)), Jan P. Mattsson(Novartis (Switzerland)), Karolina Nilsson, Jörgen Jensen, Thomas Elebring(AstraZeneca (Sweden)), Anna Uvebrant(AstraZeneca (Sweden))
Cited by 9
Related Papers
Ischemia-Induced Shift of Inhibitory and Excitatory Amino Acids from Intra- to Extracellular Compartments
|Journal of Cerebral Blood Flow & Metabolism|1985|660
Control of transient lower esophageal sphincter relaxations and reflux by the GABAB agonist baclofen in normal subjects
|Gastroenterology|2000|326
Effects of <i>In Vivo</i> Administration of Kainic Acid on the Extracellular Amino Acid Pool in the Rabbit Hippocampus
|Journal of Neurochemistry|1983|214
The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection
|Neuroscience Letters|1988|176
Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial
|The Lancet. Gastroenterology & hepatology|2018|174